首页 > 最新文献

Annals of the Child Neurology Society最新文献

英文 中文
Fenfluramine's Broader Potential: A Second Notable Electroencephalogram Response in Developmental Epileptic Encephalopathy With Spike-Wave Activation in Sleep 芬氟拉明的更广泛的潜力:睡眠中具有尖峰波激活的发展性癫痫脑病的第二个显著脑电图反应
Pub Date : 2025-06-17 DOI: 10.1002/cns3.70013
Abigail Arroyo, Douglas R. Nordli III, Fernando Galan
<p>Fenfluramine, a serotonergic agent, was first identified in the 1980s for its potential antiseizure properties, particularly in photosensitive epilepsy and later in Dravet syndrome [<span>1</span>]. Although it was withdrawn from the market in the 1990s due to concerns over cardiovascular adverse effects, including pulmonary arterial hypertension associated with high doses, subsequent studies have demonstrated that low-dose fenfluramine can be both efficacious and well-tolerated in managing refractory epilepsies [<span>2, 3</span>].</p><p>We present a second pediatric patient with developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS) in which fenfluramine was associated with marked electroencephalographic and clinical improvements, supporting its potential role as an adjunctive therapy in this challenging epilepsy phenotype.</p><p>This 6-year-old right-handed boy with DEE-SWAS was admitted to the epilepsy monitoring unit for further evaluation. He had been experiencing seizures since age 2 years, occurring multiple times daily and lasting only a few seconds. The seizure semiology was consistent with myoclonic seizures, characterized by eyelid myoclonia and bilateral arm jerks.</p><p>Initial electroencephalography (EEG) revealed a diffusely slowed background with abundant multifocal epileptiform discharges, most prominent in the bilateral temporal regions. During wakefulness, several electroclinical seizures with eyelid myoclonia were recorded. In sleep, EEG demonstrated bilaterally synchronous spike-and-wave discharges, with a spike-wave index exceeding 85% during non–rapid eye movement (NREM) sleep.</p><p>Comprehensive genetic testing—including chromosomal microarray analysis, mitochondrial DNA analysis, and whole-exome sequencing—did not identify any pathogenic variants. Magnetic resonance imaging (MRI) of the brain was also unremarkable.</p><p>At the time of admission, the patient was receiving levetiracetam, valproic acid, clobazam, and diazepam. Despite this regimen, he exhibited significant developmental regression, particularly in motor and language skills, accompanied by severe sleep disturbances that negatively impacted his overall quality of life. Previous treatments, including high-dose intravenous methylprednisolone, intravenous immunoglobulin (IVIG), and acetazolamide, had been discontinued due to ineffectiveness or uncertain benefit.</p><p>During his epilepsy monitoring unit stay, fenfluramine was initiated at a dose of 0.2 mg/kg/day, divided into two daily administrations, as an adjunct to his ongoing antiseizure medications. In parallel, the ketogenic diet was introduced as an additional therapeutic strategy for seizure control. Within 24–48 h of initiating fenfluramine, the patient's EEG exhibited a marked improvement compared with baseline (Figure 1).</p><p>This second pediatric patient with refractory epilepsy and DEE-SWAS demonstrated significant EEG improvement following initiation of fe
芬氟拉明是一种血清素能药物,因其潜在的抗癫痫特性于20世纪80年代首次被发现,特别是在光敏性癫痫和后来的德拉韦综合征中。尽管在20世纪90年代由于担心心血管不良反应(包括与高剂量相关的肺动脉高压)而退出市场,但随后的研究表明,低剂量芬氟拉明在治疗难治性癫痫方面既有效又耐受性良好[2,3]。我们报告了第二例患有发展性和癫痫性脑病伴睡眠尖峰波激活(DEE-SWAS)的儿童患者,其中芬氟拉明与显著的脑电图和临床改善相关,支持其作为辅助治疗这种具有挑战性的癫痫表型的潜在作用。这名患有DEE-SWAS的6岁右撇子男孩被送入癫痫监测部门进行进一步评估。他从2岁起就开始癫痫发作,每天发作多次,持续时间只有几秒钟。发作符号学与肌阵挛性发作一致,以眼睑肌阵挛和双侧手臂抽搐为特征。最初的脑电图(EEG)显示弥漫性慢背景和丰富的多灶性癫痫样放电,最突出的是在双侧颞区。在清醒时,记录了几次伴有眼睑肌阵挛的电临床发作。在睡眠中,脑电图显示双侧同步峰波放电,在非快速眼动(NREM)睡眠时,峰波指数超过85%。全面的基因检测——包括染色体微阵列分析、线粒体DNA分析和全外显子组测序——没有发现任何致病变异。大脑的核磁共振成像(MRI)也不明显。入院时,患者正在接受左乙拉西坦、丙戊酸、氯巴唑和地西泮。尽管如此,他还是表现出明显的发育倒退,尤其是在运动和语言技能方面,并伴有严重的睡眠障碍,这对他的整体生活质量产生了负面影响。先前的治疗,包括大剂量静脉注射甲基强的松龙、静脉注射免疫球蛋白(IVIG)和乙酰唑胺,由于无效或不确定疗效而停止。在他的癫痫监测单位期间,芬氟拉明开始以0.2 mg/kg/天的剂量,分为每天两次给药,作为他正在进行的抗癫痫药物的辅助。与此同时,生酮饮食被引入作为控制癫痫发作的额外治疗策略。在开始使用芬氟拉明的24-48小时内,患者的脑电图与基线相比有明显改善(图1)。第二例难治性癫痫和DEE-SWAS患儿在开始使用芬氟拉明(0.2 mg/kg/天)[4]后,脑电图明显改善。在开始使用芬氟拉明后,该男孩在6个月内仅经历了一次癫痫发作,目前已连续9个月无癫痫发作。他最近的脑电图(2024年11月)显示,尖峰波指数低于1%,只有罕见的左中央放电。震颤消退后停用丙戊酸,患者的接受性和表达性言语以及运动技能继续改善。生酮饮食与芬氟拉明同时开始,这可能对癫痫发作控制和认知改善有协同作用。然而,在开始使用芬氟拉明后不久,在达到治疗性酮症之前,观察到快速的脑电图和临床改善。联合治疗安全且耐受性良好,患者继续使用芬氟拉明。我们提出了芬氟拉明在第二例小儿DEE-SWAS患者中的治疗效果的新观察。当与先前记录的患者一起考虑时,这些发现表明芬氟拉明可能有更广泛的临床应用,而不是目前批准的用于Dravet综合征和lenox - gastaut综合征的适应症。虽然患者数量少,无法得出明确的结论,但观察到的一致的临床和电图改善突出了进一步研究芬氟拉明的作用机制及其在更广泛的发育性和癫痫性脑病中的潜在作用的必要性。阿比盖尔·阿罗约:写作-原始草案,写作-审查和编辑,资源,数据策展。道格拉斯R. Nordli III:写作-原始草案,写作-审查和编辑,资源,数据策展。费尔南多·加兰:写作-原稿,写作-审查和编辑,数据管理,监督,资源。作者声明无利益冲突。
{"title":"Fenfluramine's Broader Potential: A Second Notable Electroencephalogram Response in Developmental Epileptic Encephalopathy With Spike-Wave Activation in Sleep","authors":"Abigail Arroyo,&nbsp;Douglas R. Nordli III,&nbsp;Fernando Galan","doi":"10.1002/cns3.70013","DOIUrl":"https://doi.org/10.1002/cns3.70013","url":null,"abstract":"&lt;p&gt;Fenfluramine, a serotonergic agent, was first identified in the 1980s for its potential antiseizure properties, particularly in photosensitive epilepsy and later in Dravet syndrome [&lt;span&gt;1&lt;/span&gt;]. Although it was withdrawn from the market in the 1990s due to concerns over cardiovascular adverse effects, including pulmonary arterial hypertension associated with high doses, subsequent studies have demonstrated that low-dose fenfluramine can be both efficacious and well-tolerated in managing refractory epilepsies [&lt;span&gt;2, 3&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;We present a second pediatric patient with developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS) in which fenfluramine was associated with marked electroencephalographic and clinical improvements, supporting its potential role as an adjunctive therapy in this challenging epilepsy phenotype.&lt;/p&gt;&lt;p&gt;This 6-year-old right-handed boy with DEE-SWAS was admitted to the epilepsy monitoring unit for further evaluation. He had been experiencing seizures since age 2 years, occurring multiple times daily and lasting only a few seconds. The seizure semiology was consistent with myoclonic seizures, characterized by eyelid myoclonia and bilateral arm jerks.&lt;/p&gt;&lt;p&gt;Initial electroencephalography (EEG) revealed a diffusely slowed background with abundant multifocal epileptiform discharges, most prominent in the bilateral temporal regions. During wakefulness, several electroclinical seizures with eyelid myoclonia were recorded. In sleep, EEG demonstrated bilaterally synchronous spike-and-wave discharges, with a spike-wave index exceeding 85% during non–rapid eye movement (NREM) sleep.&lt;/p&gt;&lt;p&gt;Comprehensive genetic testing—including chromosomal microarray analysis, mitochondrial DNA analysis, and whole-exome sequencing—did not identify any pathogenic variants. Magnetic resonance imaging (MRI) of the brain was also unremarkable.&lt;/p&gt;&lt;p&gt;At the time of admission, the patient was receiving levetiracetam, valproic acid, clobazam, and diazepam. Despite this regimen, he exhibited significant developmental regression, particularly in motor and language skills, accompanied by severe sleep disturbances that negatively impacted his overall quality of life. Previous treatments, including high-dose intravenous methylprednisolone, intravenous immunoglobulin (IVIG), and acetazolamide, had been discontinued due to ineffectiveness or uncertain benefit.&lt;/p&gt;&lt;p&gt;During his epilepsy monitoring unit stay, fenfluramine was initiated at a dose of 0.2 mg/kg/day, divided into two daily administrations, as an adjunct to his ongoing antiseizure medications. In parallel, the ketogenic diet was introduced as an additional therapeutic strategy for seizure control. Within 24–48 h of initiating fenfluramine, the patient's EEG exhibited a marked improvement compared with baseline (Figure 1).&lt;/p&gt;&lt;p&gt;This second pediatric patient with refractory epilepsy and DEE-SWAS demonstrated significant EEG improvement following initiation of fe","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"232-234"},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145101416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza-Associated Encephalopathy 与流感相关的脑病
Pub Date : 2025-06-17 DOI: 10.1002/cns3.70010
Andrew Silverman, Chrisoula Cheronis

This previously healthy and vaccinated (except for the seasonal influenza vaccine) 12-year-old boy developed acute neurological symptoms following 3 days of fever and gastrointestinal distress. His symptoms progressed from headache and transient left-arm paresthesias to expressive aphasia, prompting emergency evaluation. He was febrile, tachycardic, and hypertensive on arrival, with fluctuating neurological deficits. Serum investigations, including blood counts, glucose, metabolic panel, urine toxicology, and anti-MOG, were normal. Influenza B was detected via nasopharyngeal swab. Magnetic resonance imaging/magnetic resonance angiography revealed confluent white matter signal changes with restricted diffusion (Figure 1) with normal vessels, consistent with an infection-triggered encephalopathy syndrome, specifically mild encephalopathy with a reversible splenial lesion (MERS) [2]. The patient's rapid clinical improvement within 24 h without treatment supported a diagnosis of influenza-associated encephalopathy (IAE), for which neuroimaging is paramount. Diffusion restriction was thought to be related to intramyelinic edema and/or inflammatory infiltrate, comparable to prior reports [1, 3]. At 3-month follow-up, he remained neurologically intact, had returned to age-appropriate schooling, and had normal repeat imaging. IAE is a rare but severe complication of influenza; the pathogenesis is not fully understood but is believed to involve dysregulated host inflammatory response to influenza, leading to varying degrees of brain dysfunction and inflammation [4, 5]. This patient with MERS with focal neurological deficits and extensive white matter involvement illustrates the variable presentation and rapid reversibility of IAE in some individuals. In contrast, more severe types of IAE require immediate neuroprotective measures in intensive care and prompt immunotherapy (namely, acute necrotizing encephalopathy) [2, 6]. Given the significant proportion of pediatric influenza-associated deaths involving IAE in the 2024-25 influenza season, prevention strategies, including seasonal influenza vaccination, remain critical [7, 8].

Andrew Silverman: conceptualization, investigation, visualization, writing – review and editing, writing – original draft. Chrisoula Cheronis: conceptualization, visualization, writing – review and editing, writing – original draft, investigation.

The authors declare no conflicts of interest.

这名以前健康并接种了疫苗(季节性流感疫苗除外)的12岁男孩在发烧和胃肠不适3天后出现急性神经系统症状。他的症状从头痛和短暂的左臂感觉异常发展到表达性失语,促使紧急评估。他到达时出现发热、心动过速和高血压,伴有波动性神经功能障碍。血清检查,包括血细胞计数、血糖、代谢组、尿毒理学和抗mog均正常。通过鼻咽拭子检测乙型流感。磁共振成像/磁共振血管造影显示白质信号与正常血管汇合,扩散受限(图1),符合感染引发的脑病综合征,特别是轻度脑病伴可逆性脾病变(MERS)[2]。患者在未经治疗的情况下在24小时内迅速临床好转,支持流感相关脑病(IAE)的诊断,对此神经影像学至关重要。扩散限制被认为与髓内水肿和/或炎症浸润有关,与先前的报道相当[1,3]。在3个月的随访中,他的神经功能完好,恢复了与年龄相适应的学校教育,重复成像正常。IAE是一种罕见但严重的流感并发症;其发病机制尚不完全清楚,但据信与宿主对流感的炎症反应失调有关,导致不同程度的脑功能障碍和炎症[4,5]。本例伴有局灶性神经功能缺损和广泛白质受累的MERS患者表明,在一些个体中,IAE的表现是可变的,并且具有快速的可逆性。相比之下,更严重的IAE类型需要在重症监护中立即采取神经保护措施并及时进行免疫治疗(即急性坏死性脑病)[2,6]。鉴于2024-25年流感季节涉及IAE的儿童流感相关死亡的很大比例,包括季节性流感疫苗接种在内的预防策略仍然至关重要[7,8]。安德鲁西尔弗曼:概念化,调查,可视化,写作-审查和编辑,写作-原始草案。Chrisoula Cheronis:概念化,可视化,写作-审查和编辑,写作-原稿,调查。作者声明无利益冲突。
{"title":"Influenza-Associated Encephalopathy","authors":"Andrew Silverman,&nbsp;Chrisoula Cheronis","doi":"10.1002/cns3.70010","DOIUrl":"https://doi.org/10.1002/cns3.70010","url":null,"abstract":"<p>This previously healthy and vaccinated (except for the seasonal influenza vaccine) 12-year-old boy developed acute neurological symptoms following 3 days of fever and gastrointestinal distress. His symptoms progressed from headache and transient left-arm paresthesias to expressive aphasia, prompting emergency evaluation. He was febrile, tachycardic, and hypertensive on arrival, with fluctuating neurological deficits. Serum investigations, including blood counts, glucose, metabolic panel, urine toxicology, and anti-MOG, were normal. Influenza B was detected via nasopharyngeal swab. Magnetic resonance imaging/magnetic resonance angiography revealed confluent white matter signal changes with restricted diffusion (Figure 1) with normal vessels, consistent with an infection-triggered encephalopathy syndrome, specifically mild encephalopathy with a reversible splenial lesion (MERS) [<span>2</span>]. The patient's rapid clinical improvement within 24 h without treatment supported a diagnosis of influenza-associated encephalopathy (IAE), for which neuroimaging is paramount. Diffusion restriction was thought to be related to intramyelinic edema and/or inflammatory infiltrate, comparable to prior reports [<span>1, 3</span>]. At 3-month follow-up, he remained neurologically intact, had returned to age-appropriate schooling, and had normal repeat imaging. IAE is a rare but severe complication of influenza; the pathogenesis is not fully understood but is believed to involve dysregulated host inflammatory response to influenza, leading to varying degrees of brain dysfunction and inflammation [<span>4, 5</span>]. This patient with MERS with focal neurological deficits and extensive white matter involvement illustrates the variable presentation and rapid reversibility of IAE in some individuals. In contrast, more severe types of IAE require immediate neuroprotective measures in intensive care and prompt immunotherapy (namely, acute necrotizing encephalopathy) [<span>2, 6</span>]. Given the significant proportion of pediatric influenza-associated deaths involving IAE in the 2024-25 influenza season, prevention strategies, including seasonal influenza vaccination, remain critical [<span>7, 8</span>].</p><p><b>Andrew Silverman:</b> conceptualization, investigation, visualization, writing – review and editing, writing – original draft. <b>Chrisoula Cheronis:</b> conceptualization, visualization, writing – review and editing, writing – original draft, investigation.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"247-248"},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145101415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries 典型Rett综合征的症状发作:初始临床严重程度量表条目分析。
Pub Date : 2025-06-16 DOI: 10.1002/cns3.70017
Alan K. Percy, Jeffrey L. Neul, Amitha Ananth, Timothy A. Benke, Eric D. Marsh

Objective

We aim to assess the clinical features of Rett syndrome (RTT) at registration into the National Institutes of Health–sponsored natural history study (NHS) using the Clinical Severity Scale (CSS).

Introduction

The CSS was established in 2000 to assess characteristics of individuals with RTT and related disorders. We analyzed the CSS at enrollment into the NHS of all individuals with classic RTT.

Methods

The CSS of 1258 individuals was used to examine three historical items (age at regression, age at onset of hand stereotypies, and head growth) and 10 clinical features at initial enrollment.

Results

Among historical items, age at regression was most prominent after age 12 months with 8% regressing before this, hand stereotypies were most common after 18 months with 30% occurring before, and head growth was substantially lower overall. Hand use, ambulation, and communication skills were reduced in most individuals.

Discussion and Conclusion

These findings reflect core clinical criteria for classic RTT and mirror the top concerns registered independently by parents or caregivers. The CSS is an important analytic tool for the association of relative differences in clinical outcome with specific MECP2 variant groups and has been important in establishing entrance criteria in RTT clinical trials. The range of age-specific CSS features will continue to inform the RTT natural natural history as well as provide stratification and selection in future clinical trials, especially those involving younger participants.

目的:使用临床严重程度量表(CSS)评估Rett综合征(RTT)在美国国立卫生研究院(nih)赞助的自然历史(NH)研究中注册时的临床特征。CSS于2000年建立,用于评估RTT及相关疾病患者的特征。我们分析了所有经典RTT患者入组时的CSS。方法:采用1258个个体的CSS,对初始入组时的3个历史项目(回归年龄、手部刻板印象发生年龄和头部生长)和10个临床特征进行检验。结果:在历史项目中,年龄在12个月后回归最突出,在此之前回归8%,手刻板印象在18个月后最常见,在此之前发生30%,头部生长总体上明显较低。大多数患者的手部使用、行走和沟通能力都有所下降。讨论和结论:这些发现反映了经典RTT的核心临床标准,反映了父母或照顾者独立登记的最关心的问题。CSS是将临床结果的相对差异与特定MECP2变异组相关联的重要分析工具,在建立RTT临床试验的进入标准方面也很重要。年龄特异性CSS特征的范围将继续为RTT NH提供信息,并在未来的临床试验中提供分层和选择,特别是那些涉及年轻参与者的临床试验。
{"title":"Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries","authors":"Alan K. Percy,&nbsp;Jeffrey L. Neul,&nbsp;Amitha Ananth,&nbsp;Timothy A. Benke,&nbsp;Eric D. Marsh","doi":"10.1002/cns3.70017","DOIUrl":"10.1002/cns3.70017","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>We aim to assess the clinical features of Rett syndrome (RTT) at registration into the National Institutes of Health–sponsored natural history study (NHS) using the Clinical Severity Scale (CSS).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The CSS was established in 2000 to assess characteristics of individuals with RTT and related disorders. We analyzed the CSS at enrollment into the NHS of all individuals with classic RTT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The CSS of 1258 individuals was used to examine three historical items (age at regression, age at onset of hand stereotypies, and head growth) and 10 clinical features at initial enrollment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among historical items, age at regression was most prominent after age 12 months with 8% regressing before this, hand stereotypies were most common after 18 months with 30% occurring before, and head growth was substantially lower overall. Hand use, ambulation, and communication skills were reduced in most individuals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>These findings reflect core clinical criteria for classic RTT and mirror the top concerns registered independently by parents or caregivers. The CSS is an important analytic tool for the association of relative differences in clinical outcome with specific <i>MECP2</i> variant groups and has been important in establishing entrance criteria in RTT clinical trials. The range of age-specific CSS features will continue to inform the RTT natural natural history as well as provide stratification and selection in future clinical trials, especially those involving younger participants.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"152-157"},"PeriodicalIF":0.0,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144980717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manganese Neurotoxicity and Familial Disorders of Manganese Transport 锰的神经毒性和锰转运的家族性疾病
Pub Date : 2025-06-12 DOI: 10.1002/cns3.70015
Sidney M. Gospe Jr.

Manganese is the 12th most common element in the Earth's crust and is an essential industrial component. Biologically, this metal plays an important role as a constituent of numerous enzymes. While manganese is required for normal biochemical and physiological processes, manganese excess can lead to significant toxicity, particularly to the central nervous system. Over the past 25 years, three inherited disorders of manganese transport have been described, leading to a model of how this essential metal is absorbed, distributed to tissues, and eliminated. The first part of this review describes the clinical features and cellular mechanisms of manganese toxicity due to occupational and environmental exposure. The remainder of the review discusses the familial disorder associated with hypomagnesemia, SLC39A8 deficiency, and the two genetic diseases resulting in hypermanganesemia, SLC30A10 deficiency and SLC39A14 deficiency. These latter two disorders are treatable, and the early recognition and institution of chelation therapy and iron supplementation can improve neurological disability. Ongoing research regarding the tissue-specific role of each transporter and their regulatory interplay, the varied mechanisms of manganese toxicity, and its treatment are also described.

锰是地壳中第12种最常见的元素,是一种重要的工业成分。在生物学上,这种金属作为许多酶的组成成分起着重要作用。虽然锰是正常生化和生理过程所必需的,但锰过量会导致严重的毒性,特别是对中枢神经系统。在过去的25年里,已经描述了三种锰运输的遗传性疾病,导致了这种必需金属如何被吸收、分布到组织和消除的模型。本综述的第一部分介绍了锰中毒的临床特点和细胞机制,由于职业和环境暴露。本综述的其余部分讨论了与低镁血症、SLC39A8缺乏症相关的家族性疾病,以及导致高镁血症、SLC30A10缺乏症和SLC39A14缺乏症的两种遗传性疾病。后两种疾病是可以治疗的,早期发现并采用螯合治疗和补铁可以改善神经功能障碍。正在进行的研究关于每个转运体的组织特异性作用和它们的调节相互作用,锰毒性的各种机制,及其治疗也进行了描述。
{"title":"Manganese Neurotoxicity and Familial Disorders of Manganese Transport","authors":"Sidney M. Gospe Jr.","doi":"10.1002/cns3.70015","DOIUrl":"https://doi.org/10.1002/cns3.70015","url":null,"abstract":"<p>Manganese is the 12th most common element in the Earth's crust and is an essential industrial component. Biologically, this metal plays an important role as a constituent of numerous enzymes. While manganese is required for normal biochemical and physiological processes, manganese excess can lead to significant toxicity, particularly to the central nervous system. Over the past 25 years, three inherited disorders of manganese transport have been described, leading to a model of how this essential metal is absorbed, distributed to tissues, and eliminated. The first part of this review describes the clinical features and cellular mechanisms of manganese toxicity due to occupational and environmental exposure. The remainder of the review discusses the familial disorder associated with hypomagnesemia, SLC39A8 deficiency, and the two genetic diseases resulting in hypermanganesemia, SLC30A10 deficiency and SLC39A14 deficiency. These latter two disorders are treatable, and the early recognition and institution of chelation therapy and iron supplementation can improve neurological disability. Ongoing research regarding the tissue-specific role of each transporter and their regulatory interplay, the varied mechanisms of manganese toxicity, and its treatment are also described.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"135-144"},"PeriodicalIF":0.0,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145101039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epilepsy of Infancy With Migrating Focal Seizures 婴儿期癫痫伴局灶性迁移
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70014
Samuel Kamoroff, Harry Abram, Fernando Galan

This 3-month-old boy had frequent recurrent events of right-arm stiffening and right head turn suggestive of focal seizures. Continuous electroencephalogram (EEG) showed subclinical focal seizures arising independently from the right occipital and left posterior head regions. These events persisted despite escalating use of lacosamide, levetiracetam, and phenobarbital. Given the patient's age, epilepsy of infancy with migrating focal seizures (EIMFS) was suspected. Early investigation with whole-exome sequencing revealed homozygous pathogenic variants in SLC12A5 (c.986C > A, p.Ala329Asp). Early recognition is vital in this epilepsy syndrome due to the difficulty in treating and subsequent prognosis. Given the expected drug resistance, early or urgent initiation of the ketogenic diet should be considered. The overall prognosis is not favorable, as poor developmental outcomes are expected.

EIMFS is a severe infantile-onset epilepsy syndrome characterized by refractory seizures, developmental delay, and migrating focal discharges [1]. SLC12A5 mutations have been identified as a cause of EIMFS, with nine patients reported to date, but KCNT1 remains responsible for about 50% of cases [2] (Figure 1). SLC12A5 encodes the potassium-chloride cotransporter KCC2, which is crucial for maintaining synaptic inhibition [3]. Mutations in SLC12A5 lead to decreased KCC2 surface expression, impaired chloride extrusion, and reduced protein glycosylation, resulting in neuronal hyperexcitability [3]. EIMFS typically presents before 6 months of age with focal motor seizures that become multifocal and intractable [2]. Treatment options are limited, but the ketogenic diet and potassium bromide have shown potential efficacy [2]. SLC12A5-related EIMFS is inherited in an autosomal recessive manner, with both de novo and inherited mutations reported [4].

Samuel Kamoroff: conceptualization, writing – original draft, writing – review and editing, data curation. Harry Abram: writing – review and editing, data curation, supervision. Fernando Galan: conceptualization, writing – review and editing, data curation, supervision.

The authors declare no conflicts of interest.

这个3个月大的男孩经常出现右臂僵硬和右头转动提示局灶性癫痫发作。连续脑电图(EEG)显示亚临床局灶性癫痫发作独立于右枕区和左后脑区。尽管拉科沙胺、左乙拉西坦和苯巴比妥的使用不断增加,这些事件仍然存在。考虑到患者的年龄,怀疑为婴儿期癫痫伴迁移局灶性发作(EIMFS)。早期全外显子组测序发现SLC12A5存在纯合子致病变异(c.986C >; A, p.Ala329Asp)。由于治疗和预后困难,早期识别对这种癫痫综合征至关重要。考虑到预期的耐药性,应考虑尽早或紧急开始生酮饮食。总体预后不佳,因为预期发育不良。EIMFS是一种严重的婴儿癫痫综合征,其特征是难治性癫痫发作、发育迟缓和移动性局灶性放电。SLC12A5突变已被确定为EIMFS的一个原因,迄今为止报告了9例患者,但KCNT1仍然负责约50%的bb0病例(图1)。SLC12A5编码氯化钾共转运蛋白KCC2,这对于维持突触抑制[3]至关重要。SLC12A5突变导致KCC2表面表达降低,氯离子挤压受损,蛋白糖基化减少,导致神经元高兴奋性[3]。EIMFS通常在6个月前表现为局灶性运动发作,并发展为多灶性难治性脑卒中。治疗选择有限,但生酮饮食和溴化钾已显示出潜在的疗效。slc12a5相关的EIMFS以常染色体隐性遗传方式遗传,新发和遗传突变均有报道。塞缪尔·卡莫罗夫:概念化,写作-原稿,写作-审查和编辑,数据管理。哈利亚伯兰:写作-审查和编辑,数据策展,监督。费尔南多·加兰:概念化,写作-审查和编辑,数据管理,监督。作者声明无利益冲突。
{"title":"Epilepsy of Infancy With Migrating Focal Seizures","authors":"Samuel Kamoroff,&nbsp;Harry Abram,&nbsp;Fernando Galan","doi":"10.1002/cns3.70014","DOIUrl":"https://doi.org/10.1002/cns3.70014","url":null,"abstract":"<p>This 3-month-old boy had frequent recurrent events of right-arm stiffening and right head turn suggestive of focal seizures. Continuous electroencephalogram (EEG) showed subclinical focal seizures arising independently from the right occipital and left posterior head regions. These events persisted despite escalating use of lacosamide, levetiracetam, and phenobarbital. Given the patient's age, epilepsy of infancy with migrating focal seizures (EIMFS) was suspected. Early investigation with whole-exome sequencing revealed homozygous pathogenic variants in <i>SLC12A5</i> (c.986C &gt; A, p.Ala329Asp). Early recognition is vital in this epilepsy syndrome due to the difficulty in treating and subsequent prognosis. Given the expected drug resistance, early or urgent initiation of the ketogenic diet should be considered. The overall prognosis is not favorable, as poor developmental outcomes are expected.</p><p>EIMFS is a severe infantile-onset epilepsy syndrome characterized by refractory seizures, developmental delay, and migrating focal discharges [<span>1</span>]. <i>SLC12A5</i> mutations have been identified as a cause of EIMFS, with nine patients reported to date, but <i>KCNT1</i> remains responsible for about 50% of cases [<span>2</span>] (Figure 1). <i>SLC12A5</i> encodes the potassium-chloride cotransporter KCC2, which is crucial for maintaining synaptic inhibition [<span>3</span>]. Mutations in <i>SLC12A5</i> lead to decreased KCC2 surface expression, impaired chloride extrusion, and reduced protein glycosylation, resulting in neuronal hyperexcitability [<span>3</span>]. EIMFS typically presents before 6 months of age with focal motor seizures that become multifocal and intractable [<span>2</span>]. Treatment options are limited, but the ketogenic diet and potassium bromide have shown potential efficacy [<span>2</span>]. <i>SLC12A5</i>-related EIMFS is inherited in an autosomal recessive manner, with both de novo and inherited mutations reported [<span>4</span>].</p><p><b>Samuel Kamoroff:</b> conceptualization, writing – original draft, writing – review and editing, data curation. <b>Harry Abram:</b> writing – review and editing, data curation, supervision. <b>Fernando Galan:</b> conceptualization, writing – review and editing, data curation, supervision.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"125-126"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Child Neurology Workforce Shortage: Challenges and Recommendations for Researching and Recruiting the Next Generation of Child Neurologists 儿童神经病学劳动力短缺:研究和招募下一代儿童神经学家的挑战和建议
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70011
Sara A. Rubin, Peter E. Davis, Miya E. Bernson-Leung

For subspecialities like child neurology in which demand is predicted to increase and further exceed supply, understanding what attracts individuals to the field and deters individuals from it is particularly valuable. To explore this, we recently surveyed medical students and residents who had completed child neurology clerkships at US medical schools within the last approximately 7 years to investigate the antecedent factors that led to interest in these clerkships and the factors that subsequently impacted residency choice, child neurology or otherwise. Current child neurology and neurodevelopmental disabilities residents (postgraduate years [PGY] 1 through 5) and current medical students who completed at least one child neurology clerkship at a US medical institution were invited to complete an online survey through their residency program coordinators/directors or clerkship coordinators/directors. While our 38 respondents gave us useful insights, our difficulty reaching a larger sample of the population of interest (likely ~1000−5000 individuals) highlights several barriers to conducting workforce research. Here, we share relevant literature and our observations on the pipeline for careers in child neurology, current research challenges, and potential paths forward.

Early exposure to child neurology is critical for sparking interest in the field. Although studies have used different definitions of “early,” frequently referring to college and medical school [1], it is becoming more apparent that no exposure is too early for igniting interest. In our study, the most common timeframe for initial exposure to neurology was during college at 39%; however, exposure in high school or earlier was almost equally as common (37%). Popular media such as books by Oliver Sacks and fictional characters like Sherlock Holmes have been cited in residency personal statements as motivating interest in neurology [2]. These exposures along with chance encounters with neurologists through personal or family experience with neurological conditions, pediatric or otherwise, appear to be relevant when medical students are planning their career paths. It remains to be explored whether the specific exposure (pediatric, e.g., a sibling with autism, or adult, e.g., a grandparent with Alzheimer's disease) influences whether one decides to go into child neurology or adult neurology, especially given the lack of awareness among premedical and medical students that child neurology is its own specialty. Studying these types of “early” exposures could be fruitful for understanding how early lifeexperiences influence motivation to enter medicine and eventual specialty choice.

Undergraduate neuroscience courses are another crucial early exposure to the field. At present, there are inequities in access to such courses, which has implications for recruiting a diverse workforce [3]. In our survey, 24% of participants indicated tha

对于像儿童神经学这样的亚专业来说,需求预计会增加,并进一步超过供应,了解是什么吸引了人们进入这个领域,又是什么阻止了人们进入这个领域,是特别有价值的。为了探讨这一点,我们最近调查了在过去大约7年内在美国医学院完成儿童神经病学见习的医学生和住院医师,以调查导致对这些见习感兴趣的先决因素以及随后影响住院医师选择的因素,儿童神经病学或其他。目前的儿童神经病学和神经发育障碍住院医师(研究生阶段[PGY] 1 - 5)和目前在美国医疗机构完成至少一次儿童神经病学实习的医科学生被邀请通过他们的住院医师项目协调员/主任或实习协调员/主任完成一项在线调查。虽然我们的38名受访者为我们提供了有用的见解,但我们难以获得更大的感兴趣人群样本(可能为~1000 - 5000人),这突出了进行劳动力研究的几个障碍。在这里,我们分享了相关文献和我们对儿童神经病学职业发展、当前研究挑战和潜在发展路径的观察。早期接触儿童神经学对于激发对该领域的兴趣至关重要。尽管研究使用了不同的“早期”定义,通常指的是大学和医学院,但越来越明显的是,任何接触都不能太早点燃兴趣。在我们的研究中,首次接触神经学的最常见时间框架是在大学期间,占39%;然而,高中或更早接触大麻的情况几乎同样普遍(37%)。在住院医生的个人陈述中,奥利弗·萨克斯(Oliver Sacks)的书等流行媒体和夏洛克·福尔摩斯(Sherlock Holmes)等虚构人物都被引用为激发人们对神经学b[2]兴趣的原因。当医学生在规划他们的职业道路时,这些接触以及通过个人或家庭经历与神经系统疾病(儿科或其他)的神经科医生的偶然相遇似乎是相关的。具体的接触(儿童,例如,患有自闭症的兄弟姐妹,或成人,例如,患有阿尔茨海默病的祖父母)是否会影响一个人决定进入儿童神经病学或成人神经病学,这还有待探索,特别是考虑到医学预科学生和医科学生缺乏意识,儿童神经病学是自己的专业。研究这些类型的“早期”接触可能有助于理解早期生活经历如何影响进入医学领域的动机和最终的专业选择。本科生的神经科学课程是另一个重要的早期接触领域。目前,在获得此类课程方面存在不公平现象,这对招聘多样化的劳动力产生了影响。在我们的调查中,24%的参与者表示他们第一次接触神经科学/神经学是在医学院。因此,认识到医学院的神经科学临床前课程往往是接触该学科的第一门课程,强调了它们对招聘的重要性。除了最大限度地提高其可及性和吸引力之外,更多地纳入儿童神经病学主题,并仔细考虑教授这些课程的教师(即包括儿童神经病学教师、临床教师等),[4]将极大地促进曝光率和兴趣。神经学学生兴趣小组和儿科兴趣小组提供了在医学院期间接触的课外机会。这些组织依靠与神经病学/儿童神经病学部门的资助和伙伴关系来最大限度地发挥影响,这在各机构之间差别很大。我们发现COVID-19大流行与学生团体参与之间存在负相关关系,在未来几年支持这些团体将非常重要。临床接触和与儿童神经科医生的互动对于激发和维持对该领域的兴趣至关重要。即使是那些在临床预科课程后对神经病学或儿童神经病学不感兴趣的学生,有时也会在随后的临床经历和指导中发展出兴趣,包括在必要的经历中,如儿科或神经病学核心见习。我们发现,在我们的调查对象中,有较高比例的人在神经病学核心职员期间接触过儿童神经病学,这比之前的劳动力研究所预期的要高(75%对28%)。这种差异有许多可能的原因,但在必要的轮转期间,更多的儿童神经学接触机会可能会增加认识和兴趣。一旦个人确定了对儿童神经病学的兴趣,他们就必须决定是否将该专业作为职业。这通常是通过参加儿童神经病学和/或神经病学轮转/选修课来完成的。 我们发现,医学院的儿童神经学见习人员通常都很受欢迎;然而,有更多的门诊接触和指导的愿望。考虑到这些反馈,并为未来的儿童神经科医生创造机会与导师联系,并获得各种实践环境的机会,将提高对儿童神经科医生“生命中不同日子”的认识,并确保学生在选择职业时做出明智的决定。就像有机会和机会增加对儿童神经学的兴趣一样,该领域的某些方面可能会让未来的儿童神经学学员感到不快。这些方面不仅包括该学科特有的问题(例如,照顾患有严重神经疾病的儿童的困难),而且还包括目前的培训结构,因为它与经济前景、工作时间、长度和组成以及整体健康有关。儿童神经科医生面临着比成人神经科医生更低的薪水和终身收入潜力。此外,至少5年的培训要求意味着儿童神经科医生必须以较低的居民收入维持自己(可能还有他们的家庭)比许多其他专业更长。这可能支持数据表明,与成人神经学学员相比,儿童神经学学员接受额外奖学金培训的比例明显较低。鉴于那些来自医学背景的人往往背负着更大的教育债务,较长的培训时间和较低的长期收入潜力可能会进一步加剧儿童神经学多样性的缺乏。与2019 - 2023年美国医学院协会(AAMC)毕业问卷调查(GQ)中所有医学生的数据相比,我们确定,在我们的调查中,报告总债务≥10万美元的受访者较少(44%对所有GQ受访者的59% - 62%)。这表明,债务程度可能影响了儿童神经病学办事员的决定。在bbb领域的领导者中,一直在讨论缩短培训时间以及缩短12个月成人神经学培训和2年普通儿科培训的具体要求。在我们的调查中,一位受访者特别提到,要求完成2年的普通儿科培训是一种威慑。招聘的其他障碍包括生活方式因素,以及由于该领域的高度专业化而缺乏可用的导师。根据2015年劳动力调查的人口统计数据显示,79.9%的儿童神经科医生是白人,与其他儿科亚专科相比,导师之间缺乏多样性可能是来自代表性不足背景的个体从事儿童神经病学研究的另一个障碍[9,10]。考虑到导致个人追求(或不追求)儿童神经病学职业的不同时间框架和经历,决定谁,如何以及何时调查未来的儿童神经学家是困难的。医学院毕业前不久或毕业后是最接近专业决定的时间,因此是最佳的。理想情况下,研究应该包括那些考虑过儿童神经学的人,即使他们最终没有从事这方面的研究。由于研究儿童神经学的医学院毕业生相对较少,为了获得足够大的样本量以得出具有统计意义和实际意义的结论,此类研究必须跨越多个机构。目前进行这种多机构研究存在障碍,因为我们遇到了外部调查分布的限制,这些限制包括在个别机构以及通过美国神经病学学会的医学生和神经病学助理主任在线社区(目前在儿童神经病学学会没有类似的结构)。此外,与易于获得的儿童神经病学住院医师项目主任和管理员的联系信息相反,没有汇编的儿童神经病学医学教育者/见习主任的电子邮件列表,也没有直接在网上查找这些信息的方法。虽然有可能通过住院医师项目管理人员接触到最近的医学院毕业生,他们是儿童神经内科住院医师,但调查这一人群无法覆盖那些在某种程度上对儿童神经内科感兴趣但决定不从事儿童神经内科住院医师的医学生,这是一个了解职业决定的宝贵群体。此外,在从本科到研究生的医学教育过渡过程中,联系信息的丢失(即医学院的电子邮件地址)使得很难纵向跟踪个人。 越来越多的骨科和国际医学毕业生寻求美国儿童神经病学住院医师也使研究未来的儿童神经学家变得复杂,因为他们需要不同的外展。增加交流和合作的渠道,建立数据库,与AAMC和美国骨科医学院协会(AACOM)合作,将有利于促进儿童神经病学事业的未来研究。确定全美各机构的所有儿童神经病学助理主任和医学教育领导,
{"title":"Child Neurology Workforce Shortage: Challenges and Recommendations for Researching and Recruiting the Next Generation of Child Neurologists","authors":"Sara A. Rubin,&nbsp;Peter E. Davis,&nbsp;Miya E. Bernson-Leung","doi":"10.1002/cns3.70011","DOIUrl":"https://doi.org/10.1002/cns3.70011","url":null,"abstract":"<p>For subspecialities like child neurology in which demand is predicted to increase and further exceed supply, understanding what attracts individuals to the field and deters individuals from it is particularly valuable. To explore this, we recently surveyed medical students and residents who had completed child neurology clerkships at US medical schools within the last approximately 7 years to investigate the antecedent factors that led to interest in these clerkships and the factors that subsequently impacted residency choice, child neurology or otherwise. Current child neurology and neurodevelopmental disabilities residents (postgraduate years [PGY] 1 through 5) and current medical students who completed at least one child neurology clerkship at a US medical institution were invited to complete an online survey through their residency program coordinators/directors or clerkship coordinators/directors. While our 38 respondents gave us useful insights, our difficulty reaching a larger sample of the population of interest (likely ~1000−5000 individuals) highlights several barriers to conducting workforce research. Here, we share relevant literature and our observations on the pipeline for careers in child neurology, current research challenges, and potential paths forward.</p><p>Early exposure to child neurology is critical for sparking interest in the field. Although studies have used different definitions of “early,” frequently referring to college and medical school [<span>1</span>], it is becoming more apparent that no exposure is too early for igniting interest. In our study, the most common timeframe for initial exposure to neurology was during college at 39%; however, exposure in high school or earlier was almost equally as common (37%). Popular media such as books by Oliver Sacks and fictional characters like Sherlock Holmes have been cited in residency personal statements as motivating interest in neurology [<span>2</span>]. These exposures along with chance encounters with neurologists through personal or family experience with neurological conditions, pediatric or otherwise, appear to be relevant when medical students are planning their career paths. It remains to be explored whether the specific exposure (pediatric, e.g., a sibling with autism, or adult, e.g., a grandparent with Alzheimer's disease) influences whether one decides to go into child neurology or adult neurology, especially given the lack of awareness among premedical and medical students that child neurology is its own specialty. Studying these types of “early” exposures could be fruitful for understanding how early lifeexperiences influence motivation to enter medicine and eventual specialty choice.</p><p>Undergraduate neuroscience courses are another crucial early exposure to the field. At present, there are inequities in access to such courses, which has implications for recruiting a diverse workforce [<span>3</span>]. In our survey, 24% of participants indicated tha","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"68-70"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report 芬氟拉明:尿药检假阳性的罕见原因:1例报告
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70012
Maria Ghawji, Meagan Hainlen, Charuta Joshi

Background

Fenfluramine is an antiseizure medication approved by the Food and Drug Administration for the treatment of Dravet syndrome in patients older than 2 years. Fenfluramine is an amphetamine derivative. It cross-reacts with amphetamines in urine drug screen immunoassays.

Patient Presentation

A 2-year-old patient with Dravet syndrome had a cardiorespiratory arrest and tested positive for amphetamines in a urine drug screen, raising concerns of child abuse. Liquid chromatography–mass spectrometry confirmed the presence of fenfluramine but did not detect amphetamines.

Conclusion

Fenfluramine can result in a false-positive amphetamine urine drug screen at the recommended dose for Dravet syndrome. Awareness of this potential cross-reactivity can prevent undue child protective services reports, especially in patients at high risk for sudden death.

背景:芬氟拉明是一种抗癫痫药物,经美国食品和药物管理局批准用于治疗2岁以上患者的Dravet综合征。芬氟拉明是一种安非他明的衍生物。它在尿液药物筛选免疫分析中与安非他明交叉反应。一名患有德拉韦综合征的2岁患者出现了心肺骤停,并在尿液药物筛查中检测出安非他明呈阳性,这引起了人们对虐待儿童的关注。液相色谱-质谱联用证实了芬氟拉明的存在,但未检测到安非他明。结论芬氟拉明在Dravet综合征推荐剂量下可导致安非他命尿药筛查假阳性。认识到这种潜在的交叉反应可以防止儿童保护服务报告不当,特别是在猝死高风险患者中。
{"title":"Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report","authors":"Maria Ghawji,&nbsp;Meagan Hainlen,&nbsp;Charuta Joshi","doi":"10.1002/cns3.70012","DOIUrl":"https://doi.org/10.1002/cns3.70012","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Fenfluramine is an antiseizure medication approved by the Food and Drug Administration for the treatment of Dravet syndrome in patients older than 2 years. Fenfluramine is an amphetamine derivative. It cross-reacts with amphetamines in urine drug screen immunoassays.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patient Presentation</h3>\u0000 \u0000 <p>A 2-year-old patient with Dravet syndrome had a cardiorespiratory arrest and tested positive for amphetamines in a urine drug screen, raising concerns of child abuse. Liquid chromatography–mass spectrometry confirmed the presence of fenfluramine but did not detect amphetamines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Fenfluramine can result in a false-positive amphetamine urine drug screen at the recommended dose for Dravet syndrome. Awareness of this potential cross-reactivity can prevent undue child protective services reports, especially in patients at high risk for sudden death.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"121-124"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone 推进火灾治疗:鞘内地塞米松的潜力
Pub Date : 2025-05-11 DOI: 10.1002/cns3.70008
Carol Park, Douglas R. Nordli III, Mohamed Taha, Henry David, Shawn Kacker, Tareq Kass-Hout, Sonam Thind, Aurelie Hanin, Sana Said, Hiba A. Haider, Douglas R. Nordli Jr.

Background

Febrile infection-related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness.

Patient Description

We describe a 12-year-old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT-DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT-DEX led to rapid seizure control and significant neurological recovery.

Conclusion

This report supports IT-DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long-term efficacy.

背景发热性感染相关癫痫综合征(FIRES)是一种罕见的破坏性癫痫综合征,其特征是发热性疾病后的难治性癫痫持续状态。我们描述了一名患有FIRES的12岁女孩,在多次抗癫痫和免疫调节治疗失败后,她对鞘内地塞米松(IT-DEX)表现出显着的临床和电反应。尽管持续的神经炎症,IT-DEX导致快速控制癫痫发作和显著的神经恢复。结论本报告支持IT-DEX作为一种有前景的干预措施,并强调需要进一步研究其机制和长期疗效。
{"title":"Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone","authors":"Carol Park,&nbsp;Douglas R. Nordli III,&nbsp;Mohamed Taha,&nbsp;Henry David,&nbsp;Shawn Kacker,&nbsp;Tareq Kass-Hout,&nbsp;Sonam Thind,&nbsp;Aurelie Hanin,&nbsp;Sana Said,&nbsp;Hiba A. Haider,&nbsp;Douglas R. Nordli Jr.","doi":"10.1002/cns3.70008","DOIUrl":"https://doi.org/10.1002/cns3.70008","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Febrile infection-related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patient Description</h3>\u0000 \u0000 <p>We describe a 12-year-old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT-DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT-DEX led to rapid seizure control and significant neurological recovery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This report supports IT-DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long-term efficacy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"115-120"},"PeriodicalIF":0.0,"publicationDate":"2025-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Rett Syndrome: The Natural History Study Journey” 更正“Rett综合征:自然史研究之旅”
Pub Date : 2025-04-18 DOI: 10.1002/cns3.70004

Percy AK, Benke TA, Marsh ED, Neul JL. Rett syndrome: The Natural History Study Journey. Ann Child Neurol Soc. 2024;2(3):189–205. doi: 10.1002/cns3.20086.

We apologize for this error.

Percy AK, Benke TA, Marsh ED, Neul JL。雷特综合症:自然史研究之旅。中华神经科杂志,2014;2(3):189-205。doi: 10.1002 / cns3.20086。我们为这个错误道歉。
{"title":"Correction to “Rett Syndrome: The Natural History Study Journey”","authors":"","doi":"10.1002/cns3.70004","DOIUrl":"https://doi.org/10.1002/cns3.70004","url":null,"abstract":"<p>Percy AK, Benke TA, Marsh ED, Neul JL. Rett syndrome: The Natural History Study Journey. <i>Ann Child Neurol Soc</i>. 2024;2(3):189–205. doi: 10.1002/cns3.20086.</p><p>We apologize for this error.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Ears of the Lynx” Sign on Brain MRI in Siblings With Spastic Paraplegia: A Case Report 兄弟姐妹痉挛性截瘫的脑MRI显示“山猫之耳”征:1例报告
Pub Date : 2025-03-25 DOI: 10.1002/cns3.20105
Qingqing Wang, Manikum Moodley

Background

Hereditary spastic paraplegia (HSP) is a rare, clinically and genetically heterogenous condition that selectively affects the terminal segment of the descending corticospinal tract of the lumbar spine area, causing lower extremity spastic weakness with or without associated complex neurological symptoms. HSP type 11 is the most common form of autosomal recessive HSP and has unique clinical and neuroimaging features.

Methods

We describe the clinical manifestations and imaging features of siblings with childhood-onset autosomal recessive HSP. Genetic testing confirmed compound heterozygous spastic paraplegia gene (SPG) 11 mutations.

Results

The older brother developed poor balance and progressive difficulty with walking starting in childhood. He also experienced poor memory and urinary incontinence. He was born preterm at 30 weeks and was developmentally delayed and cognitivly impaired. His examination revealed length-dependent corticospinal tract signs. Magnetic resonance imaging (MRI) showed thinning of the corpus callosum and periventricular signal changes. His earlier cerebral palsy (CP) diagnosis was based on the history and imaging findings, but rcognition of the “ears of the lynx” MRI sign led to the correct diagnosis of HSP 11 with the Invitae HSP gene panel. The younger sister has similar but milder manifestations and, has the same mutation as her brother.

Interpretation

Although the manifestations of HSP in children often mimic those of CP, the management and progression of HSP differ substantially.

背景:遗传性痉挛性截瘫(HSP)是一种罕见的、临床和遗传异质性的疾病,它选择性地影响腰椎区域皮质脊髓束下降末端段,导致下肢痉挛性无力,伴有或不伴有复杂的神经系统症状。11型HSP是最常见的常染色体隐性HSP,具有独特的临床和神经影像学特征。方法对兄弟姐妹儿童期常染色体隐性遗传病的临床表现和影像学特征进行分析。基因检测证实复合杂合性痉挛性截瘫基因(SPG) 11突变。结果哥哥从童年开始出现平衡能力差和进行性行走困难。他还经历了记忆力差和尿失禁。他在30周时早产,发育迟缓,认知受损。他的检查显示长度依赖的皮质脊髓束征象。磁共振成像(MRI)显示胼胝体变薄,脑室周围信号改变。他早期的脑瘫(CP)诊断是基于病史和影像学结果,但对“山猫耳”MRI征的认识导致了使用Invitae HSP基因小组正确诊断hsp11。妹妹有类似但较温和的表现,并有相同的突变,她的哥哥。虽然儿童热休克的表现通常与CP相似,但热休克的处理和进展却有很大不同。
{"title":"“Ears of the Lynx” Sign on Brain MRI in Siblings With Spastic Paraplegia: A Case Report","authors":"Qingqing Wang,&nbsp;Manikum Moodley","doi":"10.1002/cns3.20105","DOIUrl":"https://doi.org/10.1002/cns3.20105","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hereditary spastic paraplegia (HSP) is a rare, clinically and genetically heterogenous condition that selectively affects the terminal segment of the descending corticospinal tract of the lumbar spine area, causing lower extremity spastic weakness with or without associated complex neurological symptoms. HSP type 11 is the most common form of autosomal recessive HSP and has unique clinical and neuroimaging features.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We describe the clinical manifestations and imaging features of siblings with childhood-onset autosomal recessive HSP. Genetic testing confirmed compound heterozygous spastic paraplegia gene (SPG) 11 mutations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The older brother developed poor balance and progressive difficulty with walking starting in childhood. He also experienced poor memory and urinary incontinence. He was born preterm at 30 weeks and was developmentally delayed and cognitivly impaired. His examination revealed length-dependent corticospinal tract signs. Magnetic resonance imaging (MRI) showed thinning of the corpus callosum and periventricular signal changes. His earlier cerebral palsy (CP) diagnosis was based on the history and imaging findings, but rcognition of the “ears of the lynx” MRI sign led to the correct diagnosis of HSP 11 with the Invitae HSP gene panel. The younger sister has similar but milder manifestations and, has the same mutation as her brother.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interpretation</h3>\u0000 \u0000 <p>Although the manifestations of HSP in children often mimic those of CP, the management and progression of HSP differ substantially.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"105-109"},"PeriodicalIF":0.0,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.20105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of the Child Neurology Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1